Clinical Trial Update: Effect of a GnRH Analog on Hepatic Steatosis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is recruiting to assess the effect of a gonadotropin-releasing hormone (GnRH) analog on hepatic steatosis in metabolic dysfunction-asso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis
• Metabolic Dysfunction-associated Fatty Liver Disease
• Nonalcoholic Fatty Liver Disease

Drugs mentioned

• GnRH analog

Snippet

Sponsor: Aristotle University Of Thessaloniki | Conditions: Metabolic Dysfunction-Associated Steatotic Liver Disease, Nonalcoholic Fatty Liver | Phase 4 | Status: RECRUITING